INTRODUCTION
Among the common idiopathic generalized epilepsies, juvenile myoclonic epilepsy (JME) is one of the most frequent, accounting for as much as 30% of all epilepsies (1 -3) . Fifteen chromosomal loci have been so far linked to JME (4) . At present, however, mutations causing the disease have been identified only in the ion-channel encoding gene GABRA1 (5) and in the non-ion channel gene EFHC1 (6 -9) . EFHC1 encodes a protein that harbors three tandemly repeated DM10 domains of unknown function and a single EF-hand, a calcium-binding motif at the C-terminus. Mutations in EFHC1 are to date the most frequent cause of JME (8) .
Expression of EFHC1 in transfected hippocampal primary neurons produces shorter neurites and fewer branches (9) , but loss of function data supporting a function as a negative regulator of neurite growth and/or development are lacking. EFHC1 associates with the centrosome and the mitotic spindle in cultured cells (10) and more recently, EFHC1 has been proposed to be a microtubule-binding protein that regulates cell division by controlling mitotic spindle organization and by modulating neuroblast migration (11) .
Microtubules affect multiple facets of neuronal development and function, with prominent roles in the growth and maintenance of axons and dendrites (12) . The Drosophila neuromuscular junction (NMJ) synapse has been a useful genetic system in which to assay the role of the microtubule † These authors contributed equally to this work. 4248-4257 doi:10.1093/hmg/ddr352 Advance Access published on August 11, 2011 cytoskeleton and model its role in inherited neurological disease. Mutations in the microtubule-interacting protein Futsch (MAP1b) alter synaptic morphology and VAP-33A regulate synaptic bouton sprouting through interactions with microtubules (13) (14) (15) . Atypical protein kinase C controls bouton formation (16) and hereditary spastic paraplegia genes spastin and spichthyin regulate synaptic structure and growth through the control of axonal microtubules (17) (18) (19) (20) . Furthermore, the Drosophila fragile X-related gene regulates Futsch thereby modulating synaptic architecture and neurotransmission strength (21) . Microtubules are essential structural components of dendrites, and several genes have been reported to influence dendrite growth and arbor expansion through their action on microtubules (22 -24) . The important role of microtubules in dendritic arbor shape has also been shown in flies (25) . These studies indicate that microtubules play key roles in the control of neurite structure and function and that mutations perturbing microtubule dynamics are causatively linked with inherited neurological disorders.
Here, we characterize one of the two Drosophila homologs of EFHC1, CG8959, henceforth named Defhc1.1. We generated Defhc1.1 knockout (KO) Drosophila and show that mutant NMJ synapses display an aberrant increase in satellite boutons accompanied by an increase in spontaneous neurotransmitter release. Defhc1.1 binds to microtubules and overlaps in vivo with synaptic microtubules. In the NMJ synapse, disruption of Defhc1.1 function leads to a decrease in the number of microtubule loops, whose presence correlates with halted bouton division, suggesting that Defhc1.1 is a negative regulator of microtubule dynamics. Indeed, the satellite bouton phenotype is pharmacologically corrected by administration of the microtubule dynamics inhibitor vinblastine. We further show that the loss of Defhc1.1 induces overgrowth of the dendritic arbor and in vivo overexpression of Defhc1.1 substantially reduces dendrite elaboration. In contrast, overexpression of the other EFHC1 homolog (CG11048) has no effect on dendrite arborization. These results indicate that Defhc1.1 has common functions with the human EFHC1 gene and suggests that it functions as an inhibitor of neurite growth.
RESULTS

Generation of Defhc1.1 loss of function mutants
The Drosophila genome contains two EFHC1 homologs encoded by the CG8959 and CG11048 genes that we named Defhc1.1 and Defhc1.2, respectively. The two fly proteins encoded by these genes have similar homology (52%) and display analogous e-values (CG8959 versus EFHC1 ¼ e 286 ; CG11048 versus EFHC1 ¼ e
281
) when compared with human EFHC1. This study examines Defhc1.1 function in Drosophila. We generated Defhc1.1 KO flies by gene targeting through ends-out homologous recombination (26) . The targeting construct consisted of a mini-white marker gene flanked by genomic sequences surrounding the Defhc1.1 open reading frame (ORF) for homologous insertion (Fig. 1A and B) . Transgenic lines carrying the targeting donor construct were generated and homologous recombination between the donor DNA and the endogenous Defhc1.1 locus created a null allele by replacing the Defhc1.1 ORF with the mini-white transgene (Fig. 1C) . Defhc1.1 KO lines were identified by genomic PCR (Fig. 1D ) and confirmed by reverse transcription polymerase chain reaction (RT -PCR) on total RNA (Fig. 1E) . We raised antibodies against Defhc1.1 and stained different wildtype tissues and developmental stages but were unable to detect a signal. Western blot analysis failed to detect the endogenous Defhc1.1 protein in wild-type embryos, larvae or adult lysates. However, the same antibodies reveal transgenic Defhc1.1 upon in vivo overexpression. In situ hybridization was also attempted but failed to detect endogenous Defhc1.1 transcripts in wild-type animals. These results are in agreement with the observation that only a very small number of expressed sequence tags (ESTs) corresponding to the Defhc1.1 gene are reported in the databases. Together, these data suggest that in wild-type flies Defhc1.1 is expressed at very low levels.
Defhc1.1 mutants display an increased number of satellite boutons at the NMJ synapse
Homozygous null mutant Defhc1.1 flies are viable and have normal lifespan. To uncover potential neuronal phenotypes, we examined the NMJ synapse of third-instar larvae homozygous for the KO chromosome. To visualize synaptic morphology, we labeled pre-synaptic terminals with antihorseradish peroxidase (HRP), a neuronal membrane marker, and noted that Defhc1.1 mutant NMJs contained numerous satellite boutons ( Fig. 2A -D (Fig. 2E) , although the total number of NMJ boutons, excluding satellite varicosities, was similar in control and mutant larvae. To ensure that this phenotype was caused by loss of Defhc1.1 and not by second site mutations or associated genetic modifiers, we placed the Defhc1.1 KO chromosome in trans to the deficiency Df(1)ED7344 that uncovers the Defhc1.1 locus and found that Defhc1.1 ko /Df third-instar larvae had a number of satellite boutons comparable with that of the mutant line (9.0 + 0.58, n ¼ 22) (Fig. 2E) . To confirm that the increase in satellite boutons was due to a lack of Defhc1.1 in the nervous system, transgenic Defhc1.1-GFP [UAS-Defhc1.1-green fluorescent protein (GFP)] was expressed in the null mutant background with the neuronal driver elav-Gal4. Neuronal expression of these transgenes rescued the mutant phenotype restoring normal satellite bouton number (3.3 + 0.38, n ¼ 31) (Fig. 2G and H) . These results indicate that the development of supernumerary boutons is the consequence of loss of Defhc1.1 function in the nervous system and that Defhc1.1 is required presynaptically to negatively regulate bouton formation.
We characterized the localization and expression of presynaptic (Csp, BRP/nc82) and post-synaptic (discs large and glutamate receptor subunits II and III) markers (Supplementary Material, Figs. S1 and S2) in these satellite boutons. As reported for other mutants featuring excess satellite boutons (27, 28) , we found that all markers assayed were present and normally localized at supernumerary boutons, suggesting that these structures have the predicted organization of a functional bouton. We then examined whether gain of Defhc1.1 function would also cause defects in synapse formation in vivo. We analyzed the NMJ of larvae overexpressing UAS-Defhc1.1-GFP with elav-Gal4 or the motoneuronspecific driver D42-Gal4 and found that the number of normal and satellite boutons was not significantly modified when compared with controls ( Fig. 2F) . These NMJs displayed a largely normal morphology indicating that increasing Defhc1.1 levels per se does not alter bouton formation.
To determine Defhc1.1 sub-cellular localization, we examined the distribution of transgenic Defhc1.1-GFP expressed in the nervous system. Importantly, Defhc1.1-GFP was found along the entire length of the motor nerves and stained robustly all types of synaptic boutons (Supplementary Material, Fig. S3A ). GFP fluorescence was also observed throughout the body of the neurons in the larval ventral ganglion (Supplementary Material, Fig. S3B ). The synaptic localization of the Defhc1.1 protein is consistent with a role in the local regulation of bouton sprouting. In addition, expression of Defhc1.1-GFP with the type IV dendritic neuron driver ppk-Gal4 shows that Defhc1.1 also distributes to the dendritic arbor (Supplementary Material, Fig. S3C ).
Defhc1.1 mutants show increased spontaneous neurotransmitter release but normal evoked release
The observed synaptic overgrowth prompted us to analyze the functional consequences of loss of Defhc1.1 in synaptic transmission. We thus measured the basic aspects of synaptic transmission in the mutants. Recordings of excitatory junctional pontentials (EJPs) at the NMJ of third-instar larvae showed that evoked neurotransmitter release is not altered (43.67 + 1.4 mV in controls; 47.7 + 2.2 mV in mutants; P ¼ 0.18). However, Defhc1.1 mutants show a significant increase in the spontaneous neurotransmitter release (or miniature EJPs) (1.24 + 0.03 in controls; 1.62 + 0.17 in mutants; P ¼ 0.02) ( Fig. 2 I -L) . Importantly, neuronal expression of Defhc1.1-GFP in the mutant background fully rescued the increased mEJP (1.24 + 0.08). The increased mEJP frequency is likely to reflect an increase in the total number of active zones per synapse. Indeed, when Defhc1.1 mutant and control NMJs were immunostained with anti-nc82 antibody that labels active zones, we found that the total number of nc82 punctae per synapse was greater. However, when normalized to the total bouton volume, the number of nc82 punctae was comparable with that of controls (0.41 + 0.04 for controls and 0.39 + 0.02 for Defhc1.1 mutants). This suggests that increased spontaneous neurotransmitter release is caused by an increase in synapse size. These data indicate that the aberrant NMJ morphology of Defhc1.1 KO mutants correlates with abnormal spontaneous neurotransmitter release, a defect potentially relevant to the pathophysiology of epilepsy.
Defhc1.1 associates with microtubules
The regulation of microtubule organization and dynamics is crucial for axon formation and maintenance and several studies that used the Drosophila NMJ as a model have implicated microtubules in modulating synaptic growth and bouton budding (13-16,18 -21) . Because mammalian EFHC1 has been recently identified as a microtubule-binding protein (11), we tested whether the Drosophila homolog of EFHC1 was capable of associating with microtubules. Examination of Defhc1.1-myc localization in transfected Cos-7 cells showed that in resting cells the protein was distributed throughout the cytoplasm and within the nucleus (Fig. 3A) .
However, in cells undergoing mitosis, Defhc1.1 prominently overlapped with the mitotic spindle ( Fig. 3B) (10) . To test for binding of Defhc1.1 to microtubules, we performed a microtubule-binding assay using extracts from cells transfected with a Defhc1.1-myc construct, revealing that Defhc1.1 co-sediments with taxol-stabilized microtubules (Fig. 3C) . We also performed microtubule binding in vitro using bacterially produced Defhc1.1 and purified microtubules confirming that binding is direct (Supplementary Material,  Fig. S4 ). To investigate whether Defhc1.1 co-localizes with microtubules in vivo, we stained third-instar larvae expressing Defhc1.1-GFP for the microtubule-associated protein Futsch (13) . We analyzed motor nerves and synaptic terminals and found that Defhc1.1-GFP fluorescence largely overlapped with Futsch immunoreactivity, indicating that in vivo Defhc1.1 co-localizes substantially with microtubules in axons and synaptic boutons ( Fig. 3D and E ). These results demonstrate that Defhc1.1 is capable of binding physically to microtubules and that in the nervous system it associates with microtubules within axons. 
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Defhc1.1 affects microtubule cytoskeleton dynamics
Satellite boutons can be regarded as the site of potential synaptic growth by new bouton sprouting (29) . During normal synaptic growth of the Drosophila NMJ, Futsch is found in association with loops of bundled microtubules typically observed within stable boutons. In contrast, dispersion or destruction of these loops underlies bouton division or sprouting (15) . To investigate whether the increase in satellite boutons correlated with changes in the microtubule cytoskeleton, we immunolabeled Defhc1.1 KOs and controls for Futsch. Quantification of the number of Futsch-positive loops on the NMJ innervating muscle 4 showed that Defhc1.1 mutant NMJs contained a significantly smaller number of microtubule loops compared with controls (1.1 + 0.16 for Defhc1.12/2; 1.9 + 0.19 for controls; P ¼ 0.01, n ¼ 30) (Fig. 4A-C) and that satellite boutons were always devoid of loops. Instead, within the majority of Defhc1.1 mutant boutons, Futsch immunolabeling showed either a punctate or diffuse distribution (Fig. 4 A and B) (30) . These data suggest that the lack of Defhc1.1 promotes microtubule dynamic instability within synaptic terminals resulting in overgrowth and that Defhc1.1 functions as a negative modulator of microtubule dynamics to prevent this excessive growth. If additional satellite boutons are the result of increased microtubule dynamics caused by loss of Defhc1.1-dependent inhibition, we reasoned that pharmacological suppression of microtubule dynamics should revert the number of satellite boutons to wild-type levels. We treated Defhc1.1 KO flies with vinblastine, a microtubule destabilizing drug that in low doses suppresses microtubule dynamics in vivo and in vitro (31,32) and in Drosophila has been shown to ameliorate synaptic microtubule defects associated with the loss of spastin (17) . We found that vinblastine administration suppressed additional satellite boutons in Defhc1.1 KO NMJs without affecting the morphology of control synaptic terminals (treated control ¼ 3.4 + 0.18, n ¼ 29; treated Defhc ko 3.3 + 0.16, n ¼ 39) (Fig. 4D and E ). These results demonstrate that the loss of Defhc1.1 can be compensated by pharmacological inhibition of microtubule dynamics and strongly implicate Defhc1.1 in the negative regulation of bouton sprouting through the fine inhibition of the microtubule cytoskeleton dynamics locally at the synapse.
Defhc1.1 regulates dendritic arbor morphology
Axons and dendrites contain bundles of microtubules that are required for the growth and maintenance of these neurites. We thus examined the phenotypic consequences of loss and gain of Defhc1.1 function on dendrite arborization in Drosophila dendritic neurons. There are four classes of dendritic arborization neurons, named I-IV in order of increasing dendritic arbor complexity (33) . We concentrated on class IV neurons characterized by the most highly branched dendritic arbor because dendrite outgrowth depends on the microtubule cytoskeleton (25) and because the elaborate morphology of their arbor might permit to observe the subtle phenotypic irregularities we expected from manipulating Defhc1.1 expression levels.
To visualize potential dendritic arbor defects, we used the class IV-specific promoter ppk-Gal4 (34) to drive the UAS-mCD8::GFP reporter in class-IV neurons and assayed dendritic arbor morphology in third-instar larvae. We drew concentric circles 100 mm apart centered on the neuron body and counted the number of dendrite endings in the outermost circle as a measure of terminal branching and thus neurite growth. We found a small but statistically significant increase in the number of terminal endings in Defhc1.1 mutants when compared with controls (control ¼ 2.9 + 1.0; Defhc1.1 KO ¼ 8.3 + 2.3; P ¼ 0.04, n ¼ 13) (Fig. 5A, B, D) . This result is consistent with the increased number of satellite boutons observed at the NMJ synapse and suggests that the lack of Defhc1.1 induces terminal dendrite branching and outgrowth, implicating Defhc1.1 in the negative regulation of dendrite growth. This inhibitory function on dendrite arborization was assayed by expressing UAS-Defhc1.1-HA in class-IV dendritic neurons with the ppk-Gal4 driver. Strikingly, ectopic Defhc1.1 expression resulted in a substantial reduction in dendritic arbor elaboration (Fig. 5C ). In particular, the total number of dendrite termini was reduced to 50% of that of controls (control ¼ 225 + 8.4; Defhc1.1 OE ¼ 107 + 8.9; P ¼ 5.5e 27 , n ¼ 7) and total arbor length to 55% (control ¼ 9644 + 452 mm; Defhc1.1 OE ¼ 4921 + 367 mm; P ¼ 3.2e
26
, n ¼ 7) (Fig. 5E and F) . Together, loss-and gain-of-function Figure) , providing support to the idea that Defhc1.1 is likely to be the closest functional homolog of human EFHC1.
DISCUSSION
In this study, we functionally characterize the Drosophila Defhc1.1 gene homologous to EFHC1 whose mutation in humans is responsible for a form of JME (9) . A function for EFHC1 in regulation of cell division and neuronal migration has been proposed from studies on the rat developing neocortex (11), despite the reported absence of gross anatomical defects in Efhc12/2 mouse brains (35) . However, a direct link between the defects ensuing loss of EFHC1 in mammals and epileptogenesis is not apparent. Our mutant analysis of Defhc1.1 loss-and gain-of-function alleles in vivo in Drosophila revealed a number of neuronal defects that can be more promptly reconciled with epileptogenesis. EFHC1 has been demonstrated to be a microtubule-binding protein (11) . Likewise, Defhc1.1 co-sediments with polymerized microtubules in vitro and co-localizes with axonal microtubules in vivo. This observation indicates that the reported neuronal defects are potentially the result of an impairment of the neuronal microtubule cytoskeleton dynamics or organization caused by modulating the levels of Defhc1.1 expression. The elaboration of synaptic architecture is well documented to be microtubule dependent and, at the Drosophila NMJ, several known regulators of microtubule dynamics have been shown to modulate the size and complexity of the terminal arbor (13-16,18 -21) . Spastin and Dmob4/Phocein mutants, which lack a microtubule-severing protein and a regulator of microtubule dynamics respectively, have elaborate supernumerary NMJ boutons (18, 19, 30) . Likewise, loss of Defhc1.1 results in the presence of supernumerary satellite boutons at the NMJ synapse, suggesting that bouton overgrowth could be due to loss of Defhc1.1 activity on microtubules. Alterations of microtubule loops architecture have been shown to be involved in the process of bouton division at the Drosophila NMJ synapse. Microtubule loops have been associated with stable synaptic boutons, while the dispersion of these loops is typical of boutons undergoing division or sprouting (15) . Previous studies have shown that mutants characterized by supernumerary satellite boutons can display both more numerous (29) or less numerous (30) microtubule loops. In both cases, perturbation of microtubule dynamics, whose balance must be tightly regulated for normal synaptic growth, underlies these NMJ defects. We found that the number of microtubule loops identified by Futsch immunolabeling is reduced in Defhc1.1 mutant NMJs, suggesting that the loss of Defhc1.1 is likely to affect microtubule dynamics. We propose that wild-type Defhc1.1 facilitates the stabilization of microtubules and thereby decreases their dynamic instability. Under normal circumstances, this activity would force existing boutons into a more stable mode and limit the sprouting of new boutons. Robust corroboration for this functional hypothesis comes from the observation that inhibition of microtubule dynamics by pharmacological treatment of Defhc1.1 mutants with vinblastine suppresses extra satellite bouton.
The behavior of growth cone microtubules indicates that microtubule bundling is an important step in the formation of a new axonal segment. Decreased microtubule dynamics locks microtubules in a non-dynamic array, microtubules do not undergo the subsequent step of bundling and axon elongation is halted (31) . The parallel behavior of microtubules observed at the Drosophila NMJ synapse during bouton sprouting has suggested a fundamental similarity between the mechanisms of synaptic growth and the mechanisms of growth cone motility (15) . Loss of mammalian EFHC1 is thought to induce microtubule bundling (11), indicating that increased or facilitated bundling could be the mechanism underlying the synaptic overgrowth seen in response to loss of Defhc1.1 in flies. Lack of Defhc1.1 results in more dynamic and unstable microtubules which would proceed more easily through bundling, a step thought to be important for bouton division and growth. According to this model, the function of wild-type Defhc1.1 would be to restrain excessive synaptic growth by curbing the microtubule dynamic instability and its positive effects on bundling.
The role of Defhc1.1 is not restricted to the synapse. Loss and gain of Defhc1.1 function also affect the formation of the dendritic arbor, where the microtubule cytoskeleton is known to play a prominent role. Similar to its effect on synaptic bouton growth, elimination of Defhc1.1 results in an increase in terminal branching of dendritic arborization neurons, suggesting a more general role on neurite growth. Consistent with this result, Defhc1.1 overexpression causes a marked reduction in dendrite branching and complexity. This is in contrast, however, with our observations at the NMJ where ectopic expression of Defhc1.1 had no consequences on synaptic elaboration. A possible explanation for this differential effect could be that the diverse microtubule milieu within axons and dendrites (12) might render dendritic microtubules less tolerant to increased levels of Defhc1.1 than axonal microtubules. Thus, our combined data implicate Defhc1.1 as a negative regulator of neurite growth.
The overall subtle phenotypic consequences of loss of Defhc1.1 are consistent with the absence of obvious defects in EFHC1 KO mice (35) as well as with the otherwise normal phenotype of humans with JME (9). Therefore, strong phenotypic consequences would not be predicted from the loss of Defhc1.1 function. Accordingly, the modestly visible effects of Defhc1.1 elimination on microtubule cytoskeleton morphology are not surprising. It is known, for example, that low doses of vinblastine decrease microtubule dynamics and thereby abolish axonal elongation during growth cone advance (31, 32 ), yet do not visibly affect the integrity of the axonal microtubule array. Furthermore, elimination of the other EFHC1 homolog, Defhc1.2, could exacerbate the phenotypes here described due to genetic redundancy.
We also found that the lack of Defhc1.1 results in significantly increased spontaneous neurotransmitter release suggesting a correlation between the abnormal synaptic architecture of Defhc1.1 loss-of-function mutants and defects in synaptic Human Molecular Genetics, 2011, Vol. 20, No. 21 4255 activity. Our observation that Defhc1.1 KO has increased spontaneous release suggests a model in which basal level neural activity can contribute to epilepsy. The observation that the density of active zones in Defhc1.1 mutant synapses remains unaltered indicates that the increase in spontaneous fusion events depends on the increased number of active zones due to synaptic overgrowth. In conclusion, these results suggest that EFHC1 may regulate epileptogenesis by subtly increasing the extent of spontaneous vesicle fusion through a fine regulation of the microtubule cytoskeleton and that drugs affecting the dynamics of microtubules could potentially be tested in the treatment of this disease.
MATERIALS AND METHODS
Drosophila genetics
Fly culture and transgenesis were performed using standard procedures. Several transgenic lines for each construct were generated and tested. Drosophila strains used: elav-Gal4; D42-Gal4, tubulin-Gal4, UAS-mCD8-GFP (Bloomington); Mef2-Gal4, ppk-Gal4. Targeting of the Defhc1.1 genomic locus was performed using the ends-out technique as described (26) .
Molecular biology
The Defhc1.1 and Defhc1.2 full-length cDNAs were obtained by RT -PCR performed on total head RNA purified with Trizol reagent (Invitrogen). The Defhc1.1 and Defhc1.2 cDNAs were subcloned in the pUAST vector in-frame with an HA or GFP tag. The Defhc1.1 cDNA was cloned in the pcDNA3.1 vector in frame with a myc tag. The Defhc1.1 targeting construct was generated by cloning PCR-amplified 3 kb genomic fragments upstream and downstream of the Defhc1.1 ORF into the pEndsout2 vector, on both sides of a white mini-gene.
Immunohistochemistry, immunocytochemistry and in situ hybridization
Third-instar larva immunostaining and cell transfection and immunocytochemistry were carried out following standard protocols. Antibodies used: mouse anti-CSP (1:100, DSHB), anti-HRP (1:500, Jackson laboratories) rabbit anti-myc (1:200, Santa Cruz Biotechnology), mouse anti-Dlg (1:100, DSHB), mouse anti-synaptotagmin (1:100, DSHB), mouse anti-nc82 (1:20, DSHB), mouse anti-glutamate receptor II and rabbit anti-glutamate receptor III (1:5000, gift of Aaron DiAntonio), mouse anti-acetylated a-Tubulin (1:500, Sigma-Aldrich) and mouse anti-Futsch (1:100, DSHB). Secondary antibodies were Cy5 and Cy3 conjugates from Jackson laboratories and Alexa Fluor 488 conjugates from Invitrogen. Fluorescent in situ hybridization was performed as described in reference (36) .
Quantification of bouton number
Boutons were visualized with anti-CSP and anti-HRP antibodies. Neuromuscolar junctions innervating muscle 4, abdominal segments 2 and 3, were imaged. Each NMJ was counted independently by three people blind to the genotype. The bouton number represents the average of the three individual counts.
Electrophysiology
Wandering third-instar larvae were dissected in HL3 saline. Excitatory junctional potentials were recorded from muscle 6 of hemisegment A2 or A3 by stimulating the nerve at 4-6 mV at 1 Hz. Recordings were collected only from preparations where the resting membrane potential was between 260 and 270 mV. mEJP signals were recorded over a period of 180 s. Signals were digitized via Digidata 1322A at a sampling rate of 50 kHz and low pass filtered at 1 kHz. Data were processed and analyzed with pClamp 9 software. Recordings from at least nine animals of each genotype were used for data analysis.
Microtubule co-sedimentation assay
Cos-7 cells were collected 24 h after transfection and lysed in 80 mM piperazine-N,N ′ -bis(2-ethanesulfonic acid) (PIPES) (pH 7.0), 1 mM MgCl 2 , 0.5 mM ethylene glycol tetraacetic acid (EGTA) and 1.0% Triton X-100 plus protease inhibitors samples were incubated on ice for 30 min and then centrifuged (610g; 10 min at 48C). The supernatant was collected and incubated with 40 mm paclitaxel and 1 mM GTP in dimethyl sulfoxide (DMSO) or else equimolar DMSO alone for 30 min at 378C. Samples were layered over a 50% glycerol cushion containing 80 mM PIPES (pH 7.0), 1 mM MgCl 2 and 0.5 mM EGTA and then centrifuged at 100 000g at 48C for 40 min. Lysate, pellet and supernatant fractions were collected for western blot analysis. In vitro co-sedimentation was carried out using the Tubulin Polymerization Assay kit (Cytoskeleton) according to the manufacturer's instructions.
Confocal microscopy and images analysis
Images were acquired with a Nikon C1 confocal microscope and analysed with Volocity (Perkin-Elmer). Co-localization analysis was performed with Volocity. Manders' overlap coefficient indicates the percent of signal from both channels that co-localize; co-localization coefficient Mx and My indicate the percent of green pixels co-localizing with red pixels and the percent of red pixels co-localizing with green pixels, respectively. To visualize dendritic arborization neurons, a single third-instar larva was put in 80% glycerol on a slide and carefully pushed down with a cover slip. Images of dendrites in abdominal segments 4 or 5 were analyzed using Neurolucida, Autoneuron and Neuroexplorer softwares (MBF Bioscience).
Statistics
The data are presented as mean + SEM. Statistical significance was determined by using two-tailed, unpaired t-tests. The alpha level for all statistical tests was set at 0.05.
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